Table 3.
P. berghei oocyst number/mosquito and development stage proportions after a secondary, treated blood meal.
| Treatment | Replication | Stage of development* | Total (CI95%) | Examined mosquitoes | ||
|---|---|---|---|---|---|---|
| s1 (%) | s2 (%) | s3 (%) | ||||
| control | 1 | 25 (38) | 23 (37) | 12 (25) | 70 (50 - 98) | 27 |
| 2 | 15 (33) | 12 (31) | 13 (36) | 54 (42 - 70) | 92 | |
| NA 50 mg/kg | 1 | 10 (36) | 10 (36) | 8 (28) | 31 (19 - 49) | 23 |
| 2 | 30 (42) | 21 (33) | 11 (25) | 82 (68 - 100) | 112 | |
| AZA 50 mg/kg | 1 | 19 (34) | 20 (35) | 18 (31) | 61 (40 - 93) | 27 |
Secondary blood meals were carried out on mice treated with the indicated products and doses on day 7 after mosquito infection. Oocysts were evaluated on day 3 after the secondary blood meal (day 10 post infection). *s1: immature oocysts, before the formation of sporoblasts (fig. 1A); s2: immature oocysts, with visible sporoblasts and budding sporozoites (fig. 1 B1 - B2); s3: mature oocysts containing fully developed sporozoites (fig. 1C). Geometric means, only positive mosquitoes included.